BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 33600992)

  • 41. Adjuvant chemotherapy for surgically resected non-small cell lung cancer.
    Heon S; Johnson BE
    J Thorac Cardiovasc Surg; 2012 Sep; 144(3):S39-42. PubMed ID: 22502967
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Long-term outcomes after lobectomy for non-small cell lung cancer when unsuspected pN2 disease is found: A National Cancer Data Base analysis.
    Yang CF; Kumar A; Gulack BC; Mulvihill MS; Hartwig MG; Wang X; D'Amico TA; Berry MF
    J Thorac Cardiovasc Surg; 2016 May; 151(5):1380-8. PubMed ID: 26874598
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effectiveness of Postoperative or Preoperative Radiotherapy on Prognosis in Patients with Stage II Resectable Non-Small Cell Lung Cancer: A Retrospective Study Based on the SEER Database.
    Chen D; Yu J
    Medicina (Kaunas); 2021 Nov; 57(11):. PubMed ID: 34833420
    [No Abstract]   [Full Text] [Related]  

  • 44. Analysis of Patients Unable to Undergo Adjuvant Chemotherapy after Surgery in Stage IIIA/B Non-Small Cell Lung Cancer: Will They Benefit from Mediastinal Radiotherapy?
    Graeter TP; Sebastian B; Bischof M; Kugler G; Fischer JR; Schneider T
    Thorac Cardiovasc Surg; 2016 Sep; 64(6):501-6. PubMed ID: 26322832
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Skip mediastinal lymph node metastasis and lung cancer: a particular N2 subgroup with a better prognosis.
    Riquet M; Assouad J; Bagan P; Foucault C; Le Pimpec Barthes F; Dujon A; Danel C
    Ann Thorac Surg; 2005 Jan; 79(1):225-33. PubMed ID: 15620948
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The impact of multiple metastatic nodal stations on survival in patients with resectable N1 and N2 nonsmall-cell lung cancer.
    Kang CH; Ra YJ; Kim YT; Jheon SH; Sung SW; Kim JH
    Ann Thorac Surg; 2008 Oct; 86(4):1092-7. PubMed ID: 18805138
    [TBL] [Abstract][Full Text] [Related]  

  • 47. New perspective to evaluate N1 staging: The peripheral lymph node metastasis status of non-small cell lung cancer.
    Zhang J; Liu L; Wang G; Huang C; Chen Y; Zhang Y; Guo C; Li S
    Thorac Cancer; 2019 Dec; 10(12):2253-2258. PubMed ID: 31617316
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prognostic factors for lymph node negative stage I and IIA non-small cell lung cancer: multicenter experiences.
    Oven Ustaalioglu BB; Unal OU; Turan N; Bilici A; Kaya S; Eren T; Ulas A; Inal A; Berk V; Demirci U; Alici S; Bal O; Benekli M; Gumus M
    Asian Pac J Cancer Prev; 2013; 14(11):6287-92. PubMed ID: 24377519
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Surgical multimodality treatment for baseline resectable stage IIIA-N2 non-small cell lung cancer. Degree of mediastinal lymph node involvement and impact on survival.
    Decaluwé H; De Leyn P; Vansteenkiste J; Dooms C; Van Raemdonck D; Nafteux P; Coosemans W; Lerut T
    Eur J Cardiothorac Surg; 2009 Sep; 36(3):433-9. PubMed ID: 19502079
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Predictors of survival and disease-free survival in patients with resected N1 non-small cell lung cancer.
    Cerfolio RJ; Bryant AS
    Ann Thorac Surg; 2007 Jul; 84(1):182-8; discussion 189-90. PubMed ID: 17588408
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Upfront surgery as first-line therapy in selected patients with stage IIIA non-small cell lung cancer.
    Zheng D; Ye T; Hu H; Zhang Y; Sun Y; Xiang J; Chen H
    J Thorac Cardiovasc Surg; 2018 Apr; 155(4):1814-1822.e4. PubMed ID: 29221745
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Role of Postoperative Radiotherapy in Pathologic Stage IIIA (N2) Non-Small Cell Lung Cancer in a Prospective Nationwide Oncology Outcomes Database.
    Herskovic A; Mauer E; Christos P; Nagar H
    J Thorac Oncol; 2017 Feb; 12(2):302-313. PubMed ID: 27746190
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Postoperative Radiation Therapy Is Associated With Improved Overall Survival in Incompletely Resected Stage II and III Non-Small-Cell Lung Cancer.
    Wang EH; Corso CD; Rutter CE; Park HS; Chen AB; Kim AW; Wilson LD; Decker RH; Yu JB
    J Clin Oncol; 2015 Sep; 33(25):2727-34. PubMed ID: 26101240
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The prognostic factors of resected non-small cell lung cancer with chest wall invasion.
    Lee CY; Byun CS; Lee JG; Kim DJ; Cho BC; Chung KY; Park IK
    World J Surg Oncol; 2012 Jan; 10():9. PubMed ID: 22236955
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A National Analysis of Short-term Outcomes and Long-term Survival Following Thoracoscopic Versus Open Lobectomy for Clinical Stage II Non-Small-Cell Lung Cancer.
    Yang CJ; Kumar A; Deng JZ; Raman V; Lui NS; D'Amico TA; Berry MF
    Ann Surg; 2021 Mar; 273(3):595-605. PubMed ID: 30946089
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Video-Assisted Thoracoscopic Lobectomy Is the Preferred Approach Following Induction Chemotherapy.
    Kamel MK; Nasar A; Stiles BM; Altorki NK; Port JL
    J Laparoendosc Adv Surg Tech A; 2017 May; 27(5):495-500. PubMed ID: 27996367
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Nodal stage of surgically resected non-small cell lung cancer and its effect on recurrence patterns and overall survival.
    Varlotto JM; Yao AN; DeCamp MM; Ramakrishna S; Recht A; Flickinger J; Andrei A; Reed MF; Toth JW; Fizgerald TJ; Higgins K; Zheng X; Shelkey J; Medford-Davis LN; Belani C; Kelsey CR
    Int J Radiat Oncol Biol Phys; 2015 Mar; 91(4):765-73. PubMed ID: 25752390
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Advantage of post-operative oral administration of UFT (tegafur and uracil) for completely resected p-stage I-IIIa non-small cell lung cancer (NSCLC).
    Tanaka F; Miyahara R; Ohtake Y; Yanagihara K; Fukuse T; Hitomi S; Wada H
    Eur J Cardiothorac Surg; 1998 Sep; 14(3):256-62; discussion 263-4. PubMed ID: 9761434
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Local failure in resected N1 lung cancer: implications for adjuvant therapy.
    Higgins KA; Chino JP; Berry M; Ready N; Boyd J; Yoo DS; Kelsey CR
    Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):727-33. PubMed ID: 22208965
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Induction Chemotherapy is Not Superior to a Surgery-First Strategy for Clinical N1 Non-Small Cell Lung Cancer.
    Speicher PJ; Fitch ZW; Gulack BC; Yang CJ; Tong BC; Harpole DH; D'Amico TA; Berry MF; Hartwig MG
    Ann Thorac Surg; 2016 Sep; 102(3):884-894. PubMed ID: 27476819
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.